Swiss National Bank
KYTH

Swiss National Bank’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Swiss National Bank’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-25,193
Closed -$1.89M – 2724
2015
Q3 		$1.89M Buy
25,193
+5,713
+29% +$427K ﹤0.01% 1356
2015
Q2 		$1.47M Hold
19,480
– – ﹤0.01% 1538
2015
Q1 		$977K Buy
19,480
+4,000
+26% +$168K ﹤0.01% 1775
2014
Q4 		$537K Buy
15,480
+700
+5% +$24.4K ﹤0.01% 2131
2014
Q3 		$484K Hold
14,780
– – ﹤0.01% 2125
2014
Q2 		$567K Buy
14,780
+800
+6% +$27.9K ﹤0.01% 2097
2014
Q1 		$556K Buy
13,980
+3,300
+31% +$148K ﹤0.01% 2069
2013
Q4 		$398K Buy
10,680
+1,580
+17% +$65.5K ﹤0.01% 2131
2013
Q3 		$416K Buy
9,100
+5,200
+133% +$156K ﹤0.01% 2049
2013
Q2 		$105K Buy
+3,900
New +$89.2K ﹤0.01% 2466

Swiss National Bank's KYTH Position: Q4 2015 in Review

Swiss National Bank sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 25,193 shares — an estimated $1.89M sold.

Swiss National Bank first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $1.89M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Swiss National Bank reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Swiss National Bank sold 25,193 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $1.89M.
  • Swiss National Bank first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Swiss National Bank's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.89M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Swiss National Bank's 13F filing for Q4 2015, filed 3 Feb 2016.